Study Evaluating MYO-029 in Adult Muscular Dystrophy

Trial Profile

Study Evaluating MYO-029 in Adult Muscular Dystrophy

Phase of Trial: Phase I/II

Latest Information Update: 30 May 2014

At a glance

  • Drugs Stamulumab (Primary)
  • Indications Duchenne muscular dystrophy; Facioscapulohumeral muscular dystrophy; Limb girdle muscular dystrophies
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 30 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top